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ABSTRACT 33 
Introduction  34 
Recent evidence suggests an underlying movement disruption may be a core component of 35 
Autism Spectrum Disorder (ASD) and a new, accessible early biomarker.  Mobile smart 36 
technologies such as iPads contain inertial movement and touch-screen sensors capable of 37 
recording subsecond movement patterns during gameplay.  A previous pilot study employed 38 
machine learning analysis of motor patterns recorded from children 3-5 years old.  It 39 
identified those with ASD from age- and gender-matched controls with 93% accuracy, 40 
presenting an attractive assessment method suitable for use in the home, clinic or classroom.   41 
Methods and Analysis 42 
This is a Phase III prospective, diagnostic classification study designed according to the 43 
Standards for Reporting Diagnostic Accuracy Studies (STARD) guidelines.  Three cohorts 44 
are investigated: children developing typically (TD); children with a clinical diagnosis of 45 
ASD; and children with a diagnosis of another neurodevelopmental disorder (OND) that is 46 
not ASD.  The study will be completed in Glasgow, United Kingdom, and Gothenburg, 47 
Sweden.  The recruitment target is 760 children (280 TD, 280 ASD and 200 OND). Children 48 
play two games on the iPad then a third party data acquisition and analysis algorithm 49 
(Play.Care, Harimata) will classify the data as positively or negatively associated with ASD.  50 
The results are blind until data collection is complete, when the algorithm’s classification will 51 
be compared against medical diagnosis.  Furthermore, parents of participants in the ASD and 52 
OND groups will complete three questionnaires: Strengths and Difficulties Questionnaire; 53 
ESSENCE Questionnaire; and the Adaptive Behavioural Assessment System-3 or Vinelands 54 
Adaptive Behavior Scales-II.  The primary outcome measure is sensitivity and specificity of 55 
Play.Care to differentiate ASD children from TD children.  Secondary outcomes measures 56 
include the accuracy of Play.Care to differentiate ASD children from OND children.  57 
  
3 
 
 58 
Ethics and Dissemination 59 
This study was approved by the Strathclyde University Ethics Committee and the West of 60 
Scotland Research Ethics Service Committee 3. Results will be disseminated at international 61 
scientific conferences and in peer reviewed publications.   62 
Trial registration 63 
ClinicalTrials.gov ID: NCT03438994 64 
Keywords 65 
Autism, diagnosis, digital health, machine learning, motor control, smart technology 66 
ARTICLE SUMMARY 67 
Strengths and limitations of this study  68 
¥! This study tests the accuracy of a new computational serious game assessment for the 69 
early identification of autism in preschool children. 70 
¥! It is the first Phase 3 diagnostic study to evaluate an iPad-based serious game 71 
assessment for Autism Spectrum Disorder. 72 
¥! Computational analysis of motor pattern variables, rather than social and emotional 73 
variables, are employed. 74 
¥! Novel data collection methods exploit the touch-screen and inertial sensors for 75 
accurate, reliable movement measurement of children during gameplay. 76 
¥! Children with clinical diagnoses of autism are compared to typically developing 77 
controls and children with other neurodevelopmental disorders that are not autism. 78 
 79 
 80 
 81 
 82 
 83 
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 84 
INTRODUCTION 85 
Autism spectrum disorder (ASD) is a childhood neurodevelopmental disorder with a 86 
prevalence estimated as high as 1 in 59 children in the United States.1  In the UK, ca. 700,000 87 
individuals live with autism2 and the aggregate annual cost of healthcare and support is £28 88 
billion.3  Early identification and consequent early therapeutic intervention may afford family 89 
and caregivers opportunity to adjust, and can trigger early healthcare intervention and 90 
children’s services support.  Such provision can produce significant, lifelong health and 91 
economic benefit.4-7. 92 
Early diagnosis of children with autism remains complex and can be difficult to obtain.  93 
Diagnosis currently relies on specialist medical expertise with diagnostic instrumentation 94 
dependent on subjectively rated scores during child observations, parent interviews, and 95 
testing.  These instruments are time consuming, clinically demanding and can be poorly 96 
validated against population controls.  Medical diagnosis can be withheld for many years due 97 
to wait-list times or uncertainty in clinical diagnostic fit, and schools and families can 98 
struggle not knowing whether or not a child formally requires additional support needs.8 9 99 
Recent identification of motor disturbance in young children who develop ASD presents a 100 
new target for early assessment.10 11  ASD is typically considered a social and emotional 101 
disorder.  Therefore, current diagnostic instruments directly address social and emotional 102 
aspects of the syndrome.  However, motor control underpins social engagement, emotional 103 
expression, linguistic and cognitive development,12-17 and its precise subsecond form is now 104 
accessible to non-invasive, ecologically valid assessment methods from the neonatal stage 105 
onward.  These methods of motor analaysis can detect risk for neurodevelopmental disorder 106 
well before current methods allow, 18 19 20 21 but more work is needed to better characterise 107 
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these motor signatures.  In particular, characterisation of an autism-specific motor signature 108 
may serve as an accessible, non-invasive biomarker of the disorder for its early identification, 109 
but more work is needed to better define its specificity within the broad clinical population.22 110 
Children with ASD exhibit a motor signature with a clear disruption in the development of 111 
purposeful movement,10 such as delays in the attainment of motor milestones,23 24 poor 112 
coordination,25 26 unusual gait patterns,27-29 and difficulties in gross and fine motor skills 30.  113 
In a meta-analysis of all evidence, Fournier et al 11 concluded motor disruption to be a core 114 
feature of ASD.  This motor perspective is beginning to gain significant clinical and research 115 
interest 31 and although movement differences in autism have not yet entered into the 116 
diagnostic criteria, the DSM-5 32 now includes ‘awkward or clumsy gait’ as an associated 117 
symptom.  More work is now required to characterize how these motor differences manifest 118 
across the spectrum,22 and to identify their aetiology.33 34   Motor signs identified in autism 119 
require differentiation from those that extend across the wider spectrum of early symptomatic 120 
syndromes eliciting neuropsychiatric clinical examination (ESSENCE).35 121 
Recently, technological developments have miniaturised inertial movement unit sensors that 122 
now include tri-axial accelerometers, gyroscopes and magnetometers, together with touch-123 
sensitive screens integrated into mobile consumer smart devices such as phones, tablets, and 124 
wearable devices such as wristbands and watches.  These new devices provide 125 
unprecedented access to motor information with high levels of accuracy and reliability 126 
previously restricted to high-end research or clinical laboratories.  127 
At the same time, an emerging field of ‘serious games’ has established a new template for 128 
engaging children for psychological assessment or intervention in fun and playful manners 129 
while retaining a ‘serious’ scientific agenda.36-39  Serious game formats are especially 130 
attractive for children with autism, because children with ASD do not readily share the same 131 
social intentions as the researcher.  On the other hand, children with ASD and typically 132 
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developing children alike typically enjoy screen-based games and will engage these freely of 133 
their own volition, presenting an attractive and ecologically valid paradigm for assessment.  134 
In previous work, Anzulewicz, Sobota and Delafield-Butt18 tested a novel, serious smart 135 
tablet game for early identification of young children with autism.  Two attractive 136 
educational cartoon games (Duckie Deck, http://duckiedeck.com) were engineered with 137 
bespoke code to collect sensor data (touch screen and tri-axial accelerometer and gyroscope) 138 
as the children engaged for five minutes with each game.  Machine learning analysis 139 
identified those children diagnosed with autism with 93% accuracy, proving the principle 140 
that smart game identification of ASD in children was a viable solution for assessment.  141 
Furthermore, this methodology required no professional training to deploy, no verbal 142 
instructions were required to engage the child, and only limited supervision was necessary.  143 
The result of the assessment is purely statistical; no subjective coding was required.  Thus, 144 
we proposed this serious game digital health instrument could serve as an attractive addition 145 
to the diagnostician’s tool box, as a paediatric public health screening tool, or for teachers 146 
and psychologists in schools.   147 
This game is now developed into a commercial product called Play.Care that is entering its 148 
final stages of preparation by Harimata Sp.z.o.o (https://harimata.pl/) with support from a  149 
European Union Horizon 2020 Small to Medium Enterprise Instrument (Grant No. 756079) 150 
to maximise its development and availability.  This diagnostic study is a part of that grant to 151 
test with gold-standard methodology the classification accuracy of the serious game 152 
assessment, and therefore its value in educational, clinical and population screening contexts. 153 
A current best performance for a validated sub-component of the gold-standard in autism 154 
diagnosis, the Autism Diagnostic Observation Schedule (ADOS) Version 2, yields 155 
diagnostic performance of, at most, 91% sensitivity and 71% specificity, or 82% sensitivity 156 
and 88% specificity when the algorithm is adjusted to increase specificity 40.  In our previous 157 
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pilot work, the Play.Care iPad serious game assessment demonstrated a sensitivity and 158 
specificity of 83% and 85%, respectively.18  Serious game assessment by smart device 159 
appears to be an attractive resource that could improve accessibility, as well as sensitivity in 160 
autism diagnosis. 161 
The aim of this study is to validate the predictive value of the Play.Care for ASD diagnosis 162 
by conducting a multi-site, controlled diagnostic study.  Further aims include assessing the 163 
ability of Play.Care to differentiate ASD from other childhood developmental disorders.  The 164 
primary outcome measures will be sensitivity and specificity of Play.Care to detect ASD in 165 
the general population.  166 
Limitations inherent in the earlier pilot study are overcome in this diagnostic trial.  The pilot 167 
study was based on a sample of 82 children recruited from a small number of specialist day-168 
care centres in Poland.  Such limited subject recruitment is prone to selection bias and site-169 
specific effects and precludes assessment of predictive value in population-based settings.  170 
Furthermore, the pilot study employed the same dataset to train and test the machine learning 171 
algorithm.  It did so with 10 repetitions of a 10-fold cross-validation procedure that is not 172 
prone to over-fitting.  Nevertheless, it only trained and tested patterns on that particular 173 
dataset.  To alleviate both concerns, this study sets out to test the algorithm previously 174 
developed and published18 on new, blinded data obtained independently of the Play.Care 175 
software engineers and commercial concerns in an international, multisite diagnostic 176 
evaluation with a general population and clinical cohort and with Phase III clinical study 177 
structure and size.   This trial is designed to test the Play.Care assessment to determine its 178 
generalized, real-world prediction rates across the range of possible ASD expression, as well 179 
as against TD and OND variability.  Should the sensitivity and specificity of the assessment 180 
fall within clinically useful levels comparable to or exceeding current observer-rated tests 181 
(ADOS-2, Autism Diagnostic Interview - Revised; ADI-R), we expect this instrument to be 182 
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an attractive and useful addition to the diagnostic tool box, accessible to a wide range of 183 
professionals in psychiatry, paediatrics and specialist children’s services, and those in 184 
education.  This solution is attractive and timely, and benefits from a surge in machine 185 
learning analysis of smart tech data.  In our case, this is a fun, useful and mobile serious 186 
game for autism assessment. 187 
METHODS AND ANALYSIS 188 
Study Design 189 
This study is a Phase III prospective, diagnostic classification study.  The protocol follows 190 
the Standards for Reporting Diagnostic Accuracy Studies (STARD) guidelines.41  The study 191 
is a multi-centre, international trial based in Glasgow, Scotland, UK and Gothenburg, 192 
Sweden.  The Glasgow cohort comprises a clinical sample and the Gothenburg cohort 193 
comprises a general population sample.  The study has three groups of participants: children 194 
who have received a clinical diagnosis of ASD; children who have received a clinical 195 
diagnosis of an Other Neurodevelopmental Disorder (OND; see Table 2 for 196 
Inclusion/Exclusion criteria); and children developing typically (TD).  The recruitment phase 197 
of the study runs from 1st January 2018 through to 1st June 2019 with data analysis for 198 
primary and secondary outcome measures concluding and reports submitted by 31st October 199 
2019.   200 
Patient and Public Involvement 201 
The research questions addressed in this study were the result of previous dialogue between 202 
research, digital health, commercialisation, and clinical, educational, and parental need.  203 
Demand for early, accessible, and computationally accurate assessment of autism spectrum 204 
disorder was found to be growing within the context of a rise in awareness and incidence of 205 
diagnosed autism.  Yet, wait-list times remained high and demand on clinician time 206 
increased.  An accessible instrument was needed that could identify autism and differentiate it 207 
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from other neurodevelopmental disorders – the primary and secondary outcome measures of 208 
this study – with ease and reduced expert involvement.  Patient involvement helped inform 209 
recruitment patterns of this diagnostic study, particularly to fit around family care and 210 
education patterns, and especially the children’s daily routine.  The latter was an important 211 
consideration for timing subject engagement.  Educators and clinicians assisted with the early 212 
stages of pilot protocol development, ensuring the Play.Care test phase would fit alongside 213 
the normal day routine in the nursery, school, clinic, or in some cases, in the home.   214 
 215 
Participants 216 
A total of 760 children aged thirty months to five years 11 months will be recruited. Table 1 217 
illustrates the participant numbers between sites and groups and Table 2 details inclusion and 218 
exclusion criteria for each group.  219 
Table 1. Participant numbers across groups and sites 220 
Site ASD OND TD Total 
Glasgow 100 140 180 420 
Gothenburg 180 60 100 340 
Total 280 200 280 760 
 221 
Table 2. Participant inclusion and exclusion criteria 222 
Group Inclusion criteria Exclusion criteria 
All participants Aged 30 months to five years 11 
months 
 
Participants with a 
diagnosis of ASD 
Diagnosis of autism spectrum 
disorder on the basis of DSM-V 
criteria or equivalent ICD-10 
framework  
Uncorrected sensory (visual, 
hearing) impairments 
  Presence of any motor 
impairments or behavioural 
impairment that may obstruct 
testing 
 
Participants with a 
diagnosis of OND 
Other childhood developmental 
disorders including, but not limited 
to Intellectual Disability, Non-
verbal Disability, Communication 
Disability, Attention Deficit 
Sub clinical or secondary 
expressions of ASD 
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Hyperactivity Disorder and 
Developmental Coordination 
Disorder, Down’s Syndrome and 
Cerebral Palsy. 
  Uncorrected hearing or vision 
impairments 
 
TD participants Within age range Diagnosis or suspicion of  
¥! Neuropathology 
¥! Psychopathology 
¥! Sensory or motor disorder 
including mild tremors  
 223 
Group sizes were decided upon by assuming Play.Care will achieve a moderate 85% 224 
sensitivity.  In this case, a study with 200 children with ASD will yield a confidence interval 225 
with a width of ± 4.9% i.e. the final sensitivity calculation will be accurate to within this 226 
range.  The target recruitment size for this group is 280 children to afford some reduction in 227 
sensitivity or a significant non-completion or under-recruitment rate while preserving a 228 
narrow confidence interval.   The wider population recruited in this study in comparison to 229 
the earlier study may reduce sensitivity of the algorithm’s prediction, inclusion of low 230 
functioning children with ASD increases the likelihood of disengagement with, or disinterest 231 
in the Play.Care assessment, and the new recruitment strategies employed in this study may 232 
present recruitment challenges.  Assuming a similar level of specificity, the same precision 233 
will be obtained with 200 TD children.  Furthermore, if the sensitivity (or specificity) is as 234 
high as 90%, there will be 80% power to show that the sensitivity (or specificity) exceeds 235 
83.0%, and 90% power to show it exceeds 81.9%. On the other hand, if the sensitivity (or 236 
specificity) is only 70%, there will be 91% power to show that it is below 80%.  That is, if the 237 
Play.Care assessment is under performing, which is the major concern of healthcare services, 238 
this study has a high probability of detecting it.  239 
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For the Glasgow cohort, recruitment of children with ASD or OND will be facilitated through 240 
the NHS Greater Glasgow and Clyde Specialist Children’s Services, other specialist 241 
children’s centres, nurseries, and schools.  ASD and OND recruitment will occur via two 242 
streams. The first will recruit children who receive a positive diagnosis of ASD or OND 243 
following an assessment at an NHS clinic.  The second will recruit children already 244 
diagnosed with ASD or OND from specialist nurseries, preschools and development centres.  245 
Typically developing children will be recruited from local private nurseries in the Greater 246 
Glasgow area.  247 
The Gothenburg cohort is a general population sample as all children are screened for ASD 248 
within the Gothenburg area at 30 months.  Families of children screened positively for ASD 249 
are referred to the Gillberg Neuropsychiatry Centre (GNC) in Gothenburg for 250 
neuropsychiatric assessment and it is at this stage that families will be made aware of the 251 
study and asked if they would like to participate.  OND children in Gothenburg will be 252 
recruited through Speech and Language Therapists in collaboration with the GNC. 253 
Diagnostic Device 254 
The diagnostic tool under assessment in this study is the Play.Care iPad mini application, 255 
developed by Harimata Sp. z o.o., Kraków, Poland.  The assessment consists of two serious 256 
games played on the iPad.  The first is called ‘Sharing’ and requires the child to tap a piece of 257 
food to split it into four pieces, available for sharing with four cartoon game characters 258 
waiting patiently (Figure 1a).  The second game is called ‘Creativity’ and requires the child to 259 
trace the outline of a drawing and then colour it in (Figure 1b).  Each gameplay session 260 
consists of a two minute training phase where the researcher and/or parent can assist the 261 
child, and a five minute assessment phase where the child must play unassisted.  Data is 262 
collected for analysis only from the five-minute assessment phase.  Following completion of 263 
the assessment, no further participation is required.   264 
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[Figure 1 About Here] 265 
Anzulewicz, Sobota, and Delafield-Butt18 details the data analytics employed, including 266 
identification of movement patterns by calculation of more than two hundred ‘features’ that 267 
are assessed by an algorithm developed by machine learning.  This algorithm statistically 268 
determines whether or not a particular child’s gameplay fits a diagnostic classification.  It 269 
delivers a statistical prediction. 270 
The gameplay data are collected by two sets of sensors within the iPad (Figure 2): (i) the 271 
touch-screen sensor records the Cartesian coordinate of the touch and its displacement as a 272 
gesture travels across the screen with a sampling rate of ca. 60 times per second; and (ii) a tri-273 
axial accelerometer and gyroscope inertial movement unit (IMU) sensor that detects the small 274 
accelerations and rotations of the iPad device with a sampling rate of ca. 100 times per 275 
second as the child’s fingers impact on the screen and push into it giving subtle, but 276 
significant displasive forces during a gesture.  More than two hundred and sixty movement 277 
‘features’ are calculated from the raw sensor signals to characterise the child’s gameplay.  278 
These include, for example for the touch screen sensors, the duration of a gesture, its 279 
maximum velocity, deviation from a straight line, its peak acceleration, and the variance of 280 
these parameters across a gameplay session.  Features from the raw IMU sensors are 281 
similarly extracted by calculating, for example, peak acceleration and rotation for each axis, 282 
their means and standard deviations.  These features are described in full in Anzulewicz, 283 
Sobota, and Delafield-Butt.18  Altogether, ten repetitions of a ten-fold cross-validation 284 
procedure were carried out with Regularized Greedy Forest 42 machine learning enhanced 285 
with additional data collected by Harimata in collaboration with the University of Strathclyde 286 
prior to this study to produce the algorithm employed in this study.  The algorithm is fixed for 287 
the duration of the study. 288 
[Figure 2 About Here] 289 
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The iPads used in this study are commercially available Apple products currently widely used 290 
for leisure, business and research.  The iPad specifications employed here are as follows: 291 
white or black bevel, silver back iPad mini 4, 128GB.  The iOS version will be the latest 292 
version available upon purchase of the iPads. These specifications will remain fixed for the 293 
duration of the study.  Furthermore, software updates will be switched off to prevent 294 
automatic updates of iOS which may alter the sampling rate of the internal gyroscope and 295 
accelerometers.   296 
Procedure 297 
Potential participants in the ASD and OND assessment stream will first be approached by the 298 
clinician undertaking the assessment.  The family will be presented with the Patient 299 
Information Sheet (PIS) following a positive diagnosis and if the clinician judges them to be 300 
suitable participants.  The family will complete an interest slip indicating they are willing to 301 
be further contacted by the research team regarding the study.  This method was adopted to 302 
allow participation to be strictly ‘opt-in’ and to prevent the research team contacting families 303 
who had not expressed an interest in participating.  After a minimum period of 24 hours, the 304 
research team will contact interested families to ask if they would like to participate and to 305 
arrange a data collection appointment. 306 
Potential participants in the ASD and OND already diagnosed stream will be first approached 307 
at their child’s preschool where the research team will introduce the study during a parent’s 308 
evening or similar event.  At this point, the PIS will be made available and families who are 309 
interested will complete an interest slip, as above, and after a minimum of 24 hours the 310 
research team will contact them.  311 
Potential participants who are developing typically (TD) will be recruited through local 312 
private nurseries.  Nursery staff will circulate the PIS amongst parents and those who wish 313 
their child to participate will return a completed consent form to the nursery.  Prior to 314 
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completing the Play.Care assessment, informed consent will be given by the child’s parents 315 
or caregivers.  The researcher will then complete a paper-based Case Report Form (CRF) for 316 
participants in the ASD and OND groups which details study ID, Scottish Community Health 317 
Index (“CHI”) number, name, address, postcode, phone number and general practitioner (GP) 318 
details.  Participants’ CHI numbers will be recorded to allow follow up for up to 10 years 319 
following participation.  This will provide potential future insight into whether diagnoses 320 
remain consistent into adolescence and whether any other diagnoses are received.  Any 321 
further diagnoses can then be compared to the iPad data to determine any correlations 322 
between new diagnoses and movement characteristics in childhood.   323 
An additional electronic CRF (eCRF) will be completed detailing the child’s state of arousal 324 
and interest on the day of data collection, and for the ASD and OND groups, data from a 325 
number of additional psychometric instruments including the Strengths and Difficulties 326 
Questionnaire (SDQ), the Early Symptomatic Syndromes Eliciting Neurodevelopmental 327 
Clinical Examinations Questionnaire (ESSENCE-Q) and the Adaptive Behaviour Assessment 328 
System (ABAS) at Glasgow and the Vinelands Adaptive Behaviour Scale (VABS) in 329 
Gothenburg will be recorded.  In some cases, additional data will be recorded from 330 
instruments employed as part of the child’s neuropsychiatric assessment: Wechsler Preschool 331 
and Primary Scale of Intelligence (WPPSI); Autism Diagnostic Interview Revised (ADI-R); 332 
and Autism Diagnostic Observation Schedule 2 (ADOS-2).  The diagnostic criteria that 333 
determine a child’s diagnosis (ICD 10 or DSM V) will be recorded.  These psychometric 334 
instruments will be completed at an appropriate time during or following the data collection 335 
appointment.  Additionally, the Glasgow TD group will also carry out the ESSENCE-Q, 336 
SDQ, and ABAS where possible. 337 
Following completion of the CRF and eCRF, the child will complete the Play.Care 338 
assessment.  During the assessment, the iPad will be protected within a spongy back-cover 339 
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and bumper (iPad Mini2 Air Protect, Belkin, U.S.A.) and will be placed flat on the table top, 340 
where it will remain for the duration of the assessment.  Parents/caregivers will have the 341 
option to consent to their child being videotaped during the assessment.  If consent is given, a 342 
video camera will be setup and recording will begin prior to the child starting the assessment.   343 
If a participant is unable to complete the assessment (e.g. they become distracted or 344 
distressed), eCRF and CRF data will still be recorded and the participant will remain a 345 
subject in the study.  This group will be classified as “Play.Care incompletes” and will 346 
provide insight into the clinical applicability of the assessment.  This group will be monitored 347 
at monthly intervals.  If the rate of Play.Care incompletes reaches a level where it will impact 348 
the statistical power of the study, administration protocols will be reviewed and adjusted to 349 
ensure best possible compliance.  This criterion will apply to the Glasgow cohort of 350 
participants only.  The Gothenburg cohort is a general population sample and therefore 351 
participation cannot be controlled dependent on failure rates.   If a participant does not have a 352 
confirmed clinical diagnosis by the end of the study, they will fall into the category of 353 
“diagnosis failures”.  The acceptable level of diagnosis failures is 7.5%, or, up to 21 subjects 354 
in the ASD group and 15 in the OND group.  355 
Throughout the data collection phase, all members of the research team, the trial consortium 356 
and Harimata will be blinded to the Play.Care diagnostic prediction until all data have been 357 
collected.  Following data collection, clinical diagnoses will be compared with Play.Care 358 
diagnostic predictions.  The primary outcome measure is the ability of Play.Care to identify 359 
ASD cases within the general population (Gothenburg) and clinical population (Glasgow) by 360 
assessing classification efficacy against TD children.  The secondary outcome measures are 361 
the ability of Play.Care to differentiate these ASD children from OND children and to 362 
correlate movement data to adaptive behaviour scores.   363 
Conclusions 364 
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This is the first phase 3 equivalent diagnostic study to test the predictive diagnostic accuracy 365 
of a smart-tablet serious game for the early detection of autism in preschool children.   The 366 
system is based on computational analysis of motor patterns inherent in the smart tablet 367 
sensor gameplay data, with pilot data suggesting sensitivity and specificity comparable or 368 
exceeding the current gold-standard.  This new system offers the benefit of rapid 369 
computational analysis with no lengthy subjectively rated clinician-led elements to it, rather 370 
the system engages the child’s interest in an attractive tablet-based serious game with raw 371 
sensor data analysed by classification algorithm.  The instrument’s computational accuracy is 372 
tested in this multisite diagnostic study of 760 children.   373 
ETHICS AND DISSEMINATION 374 
This study was granted approval by the University of Strathclyde Ethics Committee and the 375 
West of Scotland Research Ethics Service Committee 3 (reference number: 17-WS-0223 376 
231435) for the National Health Service.  Following completion of data collection, results 377 
will be disseminated at national and international scientific conferences and in the peer 378 
reviewed scientific literature, as well as via the Laboratory for Innovation in Autism website 379 
(https://www.strath.ac.uk/research/innovationinautism/), through ClinicalTrials.gov (ID: 380 
NCT03438994), and by final report to Harimata Sp. z o.o. and the European Commission.  A 381 
lay summary of the study results will be available for participating families.    382 
 383 
ACKNOWLEDGEMENTS 384 
We are grateful to the children, their parents, teachers, and clinicians who have worked so 385 
hard to make this study possible, both in its design and in its implementation.   386 
 387 
REFERENCES  388 
  
17 
 
1. Baio J, Wiggins L, Christensen DL, et al. Prevalence of Autism Spectrum Disorder Among 389 
Children Aged 8 Years - Autism and Developmental Disabilities Monitoring 390 
Network, 11 Sites, United States, 2014. MMWR Surveill Summ 2018;67(6):1-23. doi: 391 
10.15585/mmwr.ss6706a1 [published Online First: 2018/04/28] 392 
2. Brugha TS, McManus S, Bankart J, et al. Epidemiology of autism spectrum disorders in 393 
adults in the community in England. Arch Gen Psychiatry 2011;68(5):459-65. doi: 394 
10.1001/archgenpsychiatry.2011.38 [published Online First: 2011/05/04] 395 
3. Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism : the 396 
international journal of research and practice 2009;13(3):317-36. doi: 397 
10.1177/1362361309104246 398 
4. Bradshaw J, Steiner AM, Gengoux G, et al. Feasibility and effectiveness of very early 399 
intervention for infants at-risk for autism spectrum disorder: a systematic review. J 400 
Autism Dev Disord 2015;45(3):778-94. doi: 10.1007/s10803-014-2235-2 [published 401 
Online First: 2014/09/15] 402 
5. Pickles A, Le Couteur A, Leadbitter K, et al. Parent-mediated social communication 403 
therapy for young children with autism (PACT): long-term follow-up of a randomised 404 
controlled trial. The Lancet 2016;388(10059):2501-09. doi: 10.1016/S0140-405 
6736(16)31229-6 406 
6. Peters-Scheffer N, Didden R, Korzilius H, et al. Cost comparison of early intensive 407 
behavioral intervention and treatment as usual for children with autism spectrum 408 
disorder in The Netherlands. Res Dev Disabil 2012;33(6):1763-72. doi: 409 
10.1016/j.ridd.2012.04.006 [published Online First: 2012/06/19] 410 
7. Chasson GS, Harris GE, Neely WJ. Cost Comparison of Early Intensive Behavioral 411 
Intervention and Special Education for Children with Autism. Journal of Child and 412 
Family Studies 2007;16(3):401-13. doi: 10.1007/s10826-006-9094-1 413 
8. Liptrot K. Concern as children in York face long waits for autism diagnosis. The Press 414 
2019 20 January 2019. 415 
9. Wales B. Autism assessment delay concerns across Wales. BBC News 2018 24 January 416 
2018. 417 
10. Trevarthen C, Delafield-Butt JT. Autism as a developmental disorder in intentional 418 
movement and affective engagement. Front Integr Neurosci 2013;7:49. doi: 419 
10.3389/fnint.2013.00049 420 
11. Fournier KA, Hass CJ, Naik SK, et al. Motor coordination in autism spectrum disorders: a 421 
synthesis and meta-analysis. J Autism Dev Disord 2010;40(10):1227-40. doi: 422 
10.1007/s10803-010-0981-3 [published Online First: 2010/03/03] 423 
12. Delafield-Butt J. The Emotional and Embodied Nature of Human Understanding: Sharing 424 
narratives of meaning. In: Trevarthen C, Delafield-Butt J, Dunlop A-W, eds. The 425 
Child's Curriculum: Working with the natural voices of young children. Oxford: 426 
Oxford University Press 2018. 427 
13. Delafield-Butt JT, Gangopadhyay N. Sensorimotor intentionality: The origins of 428 
intentionality in prospective agent action. Dev Rev 2013;33(4):399-425. doi: 429 
10.1016/j.dr.2013.09.001 430 
14. Delafield-Butt JT, Trevarthen C. The Ontogenesis of Narrative: From moving to 431 
meaning. Front Psychol 2015;6 doi: 10.3389/fpsyg.2015.01157 432 
15. Iverson JM. Developing language in a developing body: the relationship between motor 433 
development and language development. J Child Lang 2010;37:229-61. doi: 434 
doi:10.1017/S0305000909990432 435 
16. Trevarthen C, Delafield-Butt JT. Biology of Shared Meaning and Language 436 
Development: Regulating the Life of Narratives. In: Legerstee M, Haley D, Bornstein 437 
  
18 
 
M, eds. The Infant Mind: Origins of the Social Brain. New York: Guildford Press 438 
2013:167-99. 439 
17. Trevarthen C, Delafield-Butt JT. Development of Consciousness. In: Hopkins B, Geangu 440 
E, Linkenauger S, eds. Cambridge Encyclopedia of Child Development. Cambridge: 441 
Cambridge University Press 2017:821-35. 442 
18. Anzulewicz A, Sobota K, Delafield-Butt JT. Toward the autism motor signature: Gesture 443 
patterns during smart tablet gameplay identify children with autism. Sci Rep 2016;6 444 
doi: 10.1038/srep31107 445 
19. Delafield-Butt JT, Freer Y, Perkins J, et al. Prospective organization of neonatal arm 446 
movements: A motor foundation of embodied agency, disrupted in premature birth. 447 
Developmental Science 2018;21(6):e12693. doi: doi:10.1111/desc.12693 448 
20. Craig CM, Grealy MA, Lee DN. Detecting motor abnormalities in preterm infants. Exp 449 
Brain Res 2000;131(3):359-65. 450 
21. Taffoni F, Tamilia E, Palminteri M, et al. Ecological Sucking Monitoring of Newborns. 451 
Sensors Journal, IEEE 2013;PP(99):1-1. doi: 10.1109/JSEN.2013.2271585 452 
22. Hocking D, Caeyenberghs K. What is the Nature of Motor Impairments in Autism, Are 453 
They Diagnostically Useful, and What Are the Implications for Intervention? Current 454 
Developmental Disorders Reports 2017;4:19. doi: 10.1007/s40474-017-0109-y 455 
23. Teitelbaum O, Teitelbaum P. Does Your Baby Have Autism?: Detecting the earliest signs 456 
of autism. Garden City Park, NY: Square One Publishers 2008. 457 
24. Teitelbaum P, Teitelbaum O, Nye O, et al. Movement analysis in infancy may be useful 458 
for early diagnosis of autism. Proceedings of the National Academy of Sciences, USA 459 
1998;95:13982-87. 460 
25. Mari M, Castiello U, Marks D, et al. The reach-to-grasp movement in children with 461 
autism spectrum disorder. Philosophical Transactions of the Royal Society B -462 
Biological Sciences 2003;358:393-403. doi: 10.1098/rstb.2002.1205 463 
26. Ghaziuddin M, Butler E. Clumsiness in autism and Asperger syndrome: a further report. J 464 
Intellect Disabil Res 1998;42 ( Pt 1):43-8. [published Online First: 1998/04/16] 465 
27. Weiss MJ, Moran MF, Parker ME, et al. Gait analysis of teenagers and young adults 466 
diagnosed with autism and severe verbal communication disorders. Front Integr 467 
Neurosci 2013;7:33. doi: 10.3389/fnint.2013.00033 [published Online First: 468 
2013/06/05] 469 
28. Nayate A, Tonge BJ, Bradshaw JL, et al. Differentiation of High-Functioning Autism and 470 
Asperger's Disorder Based on Neuromotor Behaviour. J Autism Dev Disord 471 
2012;42(5):707-17. doi: 10.1007/s10803-011-1299-5 472 
29. Kindregan D, Gallagher L, Gormley J. Gait deviations in children with autism spectrum 473 
disorders: a review. Autism research and treatment 2015;2015:741480-80. doi: 474 
10.1155/2015/741480 [published Online First: 2015/04/02] 475 
30. Lloyd M, MacDonald M, Lord C. Motor Skills of Toddlers with Autism Spectrum 476 
Disorders. Autism : the international journal of research and practice 477 
2013;17(2):133-46. doi: 10.1177/1362361311402230 478 
31. Torres EB, Donnellan AM, editors. Autism: The Movement Perspective: Nature Frontiers 479 
Group, 2013. 480 
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 481 
(5th ed.). Washington DC: American Psychiatric Association 2013. 482 
33. Bosco P, Giuliano A, Delafield-Butt J, et al. Brainstem enlargement in preschool children 483 
with autism: Results from an intermethod agreement study of segmentation 484 
algorithms. Hum Brain Mapp 2019;40(1):7-19. doi: doi:10.1002/hbm.24351 485 
  
19 
 
34. Delafield-Butt J, Trevarthen C. On the Brainstem Origin of Autism: Disruption to 486 
Movements of the Primary Self. In: Torres E, Whyatt C, eds. Autism: The Movement 487 
Sensing Perspective: Taylor & Francis CRC Press 2017. 488 
35. Hatakenaka Y, Kotani H, Yasumitsu-Lovell K, et al. Infant Motor Delay and Early 489 
Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations in 490 
Japan. Pediatr Neurol 2016;54:55-63. doi: 10.1016/j.pediatrneurol.2015.09.008 491 
[published Online First: 2015/12/27] 492 
36. Chen J, Wang G, Zhang K, et al. A pilot study on evaluating children with autism 493 
spectrum disorder using computer games. Comput Human Behav 2019;90:204-14. 494 
doi: https://doi.org/10.1016/j.chb.2018.08.057 495 
37. Noor H, Shahbodin F, Pramudya G, et al. A prototype development of visual perception 496 
diagnosis games for autism children. International Journal of ADVANCED AND 497 
APPLIED SCIENCES 2017;4(3):68-72. doi: 10.21833/ijaas.2017.03.011 498 
38. Zakari HM, Ma M, Simmons D. A Review of Serious Games for Children with Autism 499 
Spectrum Disorders (ASD). In: M. M, M.F. O, J. BH, eds. Serious Games 500 
Development and Applications SGDA 2014 Lecture Notes in Computer Science, . 501 
Cham: Springer 2014:93-106. 502 
39. Fleming TM, Bavin L, Stasiak K, et al. Serious Games and Gamification for Mental 503 
Health: Current Status and Promising Directions. Frontiers in Psychiatry 2017;7(215) 504 
doi: 10.3389/fpsyt.2016.00215 505 
40. de Bildt A, Sytema S, van Lang NDJ, et al. Evaluation of the ADOS Revised Algorithm: 506 
The Applicability in 558 Dutch Children and Adolescents. J Autism Dev Disord 507 
2009;39(9):1350-58. doi: 10.1007/s10803-009-0749-9 508 
41. Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: An Updated List of Essential 509 
Items for Reporting Diagnostic Accuracy Studies. Radiology 2015;277(3):826-32. 510 
doi: 10.1148/radiol.2015151516 [published Online First: 2015/10/29] 511 
42. Johnson R, Tong Z. Learning Nonlinear Functions Using Regularized Greedy Forest. 512 
Pattern Analysis and Machine Intelligence, IEEE Transactions on 2014;36(5):942-54. 513 
doi: 10.1109/TPAMI.2013.159 514 
 515 
AUTHOR STATEMENT  516 
JDB, CG, HM, PR, PW, LT, AM, KS, and AA produced the study design.  LM, JDB, CG, 517 
HM, PR, AM, PW, and LT developed the study protocol with input from KS and AA. 518 
Sample size calculations were carried out by AM. KS, AA & JDB were responsible for 519 
technical development and pilot work. This paper was written by LM & JDB with input from 520 
all co-authors. 521 
DATA STATEMENT  522 
Data obtained in this trial will be held by the University of Strathclyde and the funder for use 523 
within the trial research consortium (authors) for a period of up to 10 years.  All scientific 524 
  
20 
 
results will be published in the peer-reviewed literature.  The funder retains the right to a 2-525 
year embargo on such publication.   526 
CONFLICTS OF INTEREST  527 
The academic authors LM, HM, PW, AM, PR, CG, and JDB are members of the Trial 528 
Steering and Management Committees and declare no financial interest in this product or the 529 
funding company, Harimata sp. z o.o.  Co-authors AA and KS are board members of the 530 
Harimata sp. z o.o that intends to commercialise the Play.Care assessment technology.  AA 531 
and KS have options vesting in the company.  AA is a voting member of the Trial Steering 532 
Committee. 533 
FUNDING  534 
This work was subcontracted to the University of Strathclyde by Harimata sp. z o.o. as part of 535 
a Horizon 2020 SME instrument, grant number 756079. 536 
 537 
 538 
 539 
 540 
 541 
 542 
 543 
 544 
 545 
 546 
 547 
 548 
 549 
 550 
  
21 
 
 551 
 552 
 553 
Figure 1.  Play.Care assessment serious games.   (A) ‘Sharing’.  The child taps the fruit to divide it 554 
into four pieces for sharing amongst the game characters.  When all four characters have a slice of 555 
fruit, they express happiness for three seconds before the fruit is replaced with another food and the 556 
characters return to their original positions.  (B) ‘Creativity’. The child is free to choose an object or 557 
animal they wish to trace and then colour in freely by choosing a colour form the colour wheel.  If the 558 
child is satisfied with their colouring, a new shape can be chosen by selecting the green button at the 559 
top of the screen, and the process repeats.   560 
 561 
 562 
 563 
 564 
 565 
!566 
 567 
Figure 2. Movement data acquisition.  (A) A child engages freely with the serious game.  The tablet 568 
is protected by a bumper and placed firmly on a table.  Movement data are acquired from (B) the 569 
touch screen and (C) the inertial movement unit sensor that detect the kinematics and contact forces 570 
of a gesture, respectively. 571 
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